Mutlu, Y. G. Et Al. 2023. Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case. FRONTIERS IN IMMUNOLOGY , vol.14 .

Mutlu, Y. G., Yıgıt Kaya, S., Maral, S., Melek, E., Başlar, Z., Kaynar, L., ... Sevindik, Ö. G.(2023). Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case. FRONTIERS IN IMMUNOLOGY , vol.14.

Mutlu, YAŞA Et Al. "Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case," FRONTIERS IN IMMUNOLOGY , vol.14, 2023

Mutlu, YAŞA G. Et Al. "Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case." FRONTIERS IN IMMUNOLOGY , vol.14, 2023

Mutlu, Y. G. Et Al. (2023) . "Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case." FRONTIERS IN IMMUNOLOGY , vol.14.

@article{article, author={YAŞA GÜL MUTLU Et Al. }, title={Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case}, journal={FRONTIERS IN IMMUNOLOGY}, year=2023}